| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4019334 | Journal of Cataract & Refractive Surgery | 2008 | 4 Pages |
Abstract
Higher aqueous levels and greater PGE2 inhibition were observed in cataract surgery patients treated with ketorolac 0.4% than in patients treated with bromfenac 0.09% at trough dosing. These findings suggest that ketorolac 0.4% administered 4 times a day may provide better control of prostaglandin-mediated inflammation than bromfenac 0.09% administered twice a day.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Frank A. MD, L. David PhD,